Cancer Information
Participate in Our Forums
View Our Partners
Treatment Options From the Experts
Newly Diagnosed Follicular Lymphoma and Unresectable Locally Advanced and Metastatic Non-Small-Cell Lung Cancer
GRACE has partnered with Clinical Care Options to develop interactive online patient tools to help you understand more about your disease and treatment options. Answer a series of multiple-choice questions and then get treatment options chosen by experts in that field of oncology.
For more details visit https://cancergrace.org/post/treatment-options-5-experts-newly-diagnosed-follicular-lymphoma-online-tool for a diagnosis of Follicular Lymphoma, and https://cancergrace.org/post/treatment-choices-5-experts-unresectable-locally-advanced-and-metastatic-non-small-cell-lung for a diagnosis of Unresectable Locally Advanced and Metastatic Non-Small Cell Lung Cancer.
Featured Content
We are excited to launch our second year of this exciting program - Patient Perspectives - Clinical Trials Experiences Through Storytelling GRACE’s mission is to provide expert-mediated information directly to cancer patients and their caregivers to empower them to become direct partners in their cancer treatment. The Clinical Trials Experiences Through Storytelling program helps patients to become educators and to help others learn about the journey they may be beginning or continuing on. To...
The 2021 Targeted Therapies Patient Forum, presented live-online, featured top oncologists in their field discussing the most current and emerging information in targeted therapies, and answering patient questions in real-time. For the full agenda, visit https://cancergrace.org/2021-targeted-therapies-patient-forum-agenda, and for information on the faculty, https://cancergrace.org/2021-targeted-therapies-patient-forum-faculty. For a first glance at the full playlist of videos, visit the event...
In this video series, GRACE Board Members Dr. H. Jack West, Dr. Jared Weiss, and Dr. Ben Levy have continued candid discussions regarding cancer and COVID-19. In this continued time of social distancing and limiting clinic exposure, the doctors sat down to virtually discuss some of the questions we all hear regarding these unprecedented times, and how they affect primarily cancer patients. In this video, the discussion is surrounding the variable acceptance of the COVID19 vaccine. Thanks to...
Drs. H. Jack West, Joan Schiller, and Isabel Preeshagul gathered (virtually) to review information presented at ASCO and ESMO for 2021. For this series, the doctors discuss new trials for patients with NSCLC. In this video, the doctors discuss IMpower010, and Adjuvant Atezolizumab After Chemotherapy in Resected Stage I-IIIA NSCLC.
GRACE has partnered with Lilly Oncology for the REThink Testing Campaign for Lung Cancer Awareness Month BRIDGING The Biomarker Gaps More than 1.8 million Americans will face a new cancer diagnosis this year. Each of these cases is unique. Biomarker testing gives you more knowledge and helps empower well-informed treatment decisions. For Lung Cancer Awareness Month, we have partnered with Lilly Oncology to help spread the word and education about biomarker testing, and the important role it...
Community Forum
I appreciate the comments. I also want to correct my mistake in CEA level- I forgot the decimal. In the past year, my level has increased from 4.7 to 28.3, NOT...
Hi Rick and welcome to Grace. I'm sorry you're going through this. Ethically or legally we can't comment on reports.
Cancer and infection look alike on film and they both cause...
I just saw this link on our fb page. Scanxiety is unfortunately real enough to have a term everyone knows. Cancer or no (and I'm going for no) you can use...
I completely understand about not being able to comment on reports, I appreciate the support and positive thinking. I am at peace now and am going to remain hopeful-positive until we...
I hope you keep us posted. and Waiting is always the hardest part.
Hi snickerdoodle, I'm sorry you're going through this worry. Cea levels for nsclc don't really inform treatment decisions. They sometimes forewarn the coming of progression but sometimes progression doesn't follow a...